Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study Evaluating the Safety and Efficacy of Different Doses of IW-1973 Over 12 Weeks in Patients With Heart Failure With Preserved Ejection Fraction

NCT03254485 is registered in ClinicalTrials.gov with Akebia Therapeutics as lead sponsor.

NCT NCT03254485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03254485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study Evaluating the Safety and Efficacy of Different Doses of IW-1973 Over 12 Weeks in Patients With Heart Failure With Preserved Ejection Fraction
Lead sponsor
Akebia Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
November 7, 2017
Completion date
August 19, 2019
Enrollment
196 (actual)
Sites
62

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with preserved ejection fraction